These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31710183)

  • 1. High expression of COPB2 predicts adverse outcomes: A potential therapeutic target for glioma.
    Zhou Y; Wang X; Huang X; Li XD; Cheng K; Yu H; Zhou YJ; Lv P; Jiang XB
    CNS Neurosci Ther; 2020 Mar; 26(3):309-318. PubMed ID: 31710183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and clinical characterization of PARP9 in gliomas: A potential immunotherapeutic target.
    Xu H; Chai S; Wang Y; Wang J; Xiao D; Li J; Xiong N
    CNS Neurosci Ther; 2020 Aug; 26(8):804-814. PubMed ID: 32678519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COPB2: A Novel Prognostic Biomarker That Affects Progression of HCC.
    Zhang J; Wang X; Li G; He J; Lu Z; Yang Y; Jiang Y; Jiang L; Li F; Liu J
    Biomed Res Int; 2021; 2021():6648078. PubMed ID: 33824874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and clinical features of a potential immunotherapy target ELK3 in glioma.
    Xu H; Zhang L; Gao J; Wang J; Wang Y; Xiao D; Chai S
    Medicine (Baltimore); 2022 Jul; 101(30):e29544. PubMed ID: 35905257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coatomer subunit beta 2 (COPB2), identified by label-free quantitative proteomics, regulates cell proliferation and apoptosis in human prostate carcinoma cells.
    Mi Y; Sun C; Wei B; Sun F; Guo Y; Hu Q; Ding W; Zhu L; Xia G
    Biochem Biophys Res Commun; 2018 Jan; 495(1):473-480. PubMed ID: 29129687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ARL3 is downregulated and acts as a prognostic biomarker in glioma.
    Wang Y; Zhao W; Liu X; Guan G; Zhuang M
    J Transl Med; 2019 Jun; 17(1):210. PubMed ID: 31234870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SYT16 is a prognostic biomarker and correlated with immune infiltrates in glioma: A study based on TCGA data.
    Chen J; Wang Z; Wang W; Ren S; Xue J; Zhong L; Jiang T; Wei H; Zhang C
    Int Immunopharmacol; 2020 Jul; 84():106490. PubMed ID: 32289666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COPB2 promotes cell proliferation and tumorigenesis through up-regulating YAP1 expression in lung adenocarcinoma cells.
    Pu X; Wang J; Li W; Fan W; Wang L; Mao Y; Yang S; Liu S; Xu J; Lv Z; Xu L; Shu Y
    Biomed Pharmacother; 2018 Jul; 103():373-380. PubMed ID: 29674272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nuclear transport-related gene signature combined with IDH mutation and 1p/19q codeletion better predicts the prognosis of glioma patients.
    Zhu Z; Lan Y; Wang L; Ge J; Wang J; Liu F; He Z; Zhang H; Luo M; Lin D; Tan Y; Xu Y; Luo T
    BMC Cancer; 2020 Nov; 20(1):1072. PubMed ID: 33167941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Integrative Pan-Cancer Analysis of the Oncogenic Role of COPB2 in Human Tumors.
    Wu B; Wu Y; Guo X; Yue Y; Li Y; He X; Chen Y; Zhao W; Liu J; Wu X; Shen A; Zhang S
    Biomed Res Int; 2021; 2021():7405322. PubMed ID: 34676262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collagen Type III Alpha 1 chain regulated by GATA-Binding Protein 6 affects Type II IFN response and propanoate metabolism in the recurrence of lower grade glioma.
    Huang R; Li Z; Zhu X; Yan P; Song D; Yin H; Hu P; Lin R; Wu S; Meng T; Zhang J; Huang Z
    J Cell Mol Med; 2020 Sep; 24(18):10803-10815. PubMed ID: 32757451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico identification of the prognostic biomarkers and therapeutic targets associated with cancer stem cell characteristics of glioma.
    Lvu W; Fei X; Chen C; Zhang B
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32725165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of SEC61G as a Novel Prognostic Marker for Predicting Survival and Response to Therapies in Patients with Glioblastoma.
    Liu B; Liu J; Liao Y; Jin C; Zhang Z; Zhao J; Liu K; Huang H; Cao H; Cheng Q
    Med Sci Monit; 2019 May; 25():3624-3635. PubMed ID: 31094363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated Gene Expression and Methylation Analyses Identify DLL3 as a Biomarker for Prognosis of Malignant Glioma.
    Maimaiti A; Wang X; Hao Y; Jiang L; Shi X; Pei Y; Feng Z; Kasimu M
    J Mol Neurosci; 2021 Aug; 71(8):1622-1635. PubMed ID: 33713320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFI30 expression is an independent unfavourable prognostic factor in glioma.
    Liu X; Song C; Yang S; Ji Q; Chen F; Li W
    J Cell Mol Med; 2020 Nov; 24(21):12433-12443. PubMed ID: 32969157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of beta-2 microglobulin expression on the survival of glioma patients via modulating the tumor immune microenvironment.
    Tang F; Zhao YH; Zhang Q; Wei W; Tian SF; Li C; Yao J; Wang ZF; Li ZQ
    CNS Neurosci Ther; 2021 Aug; 27(8):951-962. PubMed ID: 33960680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and clinical characterization of TMEM71 expression at the transcriptional level in glioma.
    Wang KY; Huang RY; Tong XZ; Zhang KN; Liu YW; Zeng F; Hu HM; Jiang T
    CNS Neurosci Ther; 2019 Sep; 25(9):965-975. PubMed ID: 31180187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CNN3 in glioma: The prognostic factor and a potential immunotherapeutic target.
    Xu H; Chai SS; Lv P; Wang JJ
    Medicine (Baltimore); 2021 Nov; 100(46):e27931. PubMed ID: 34797350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PLEKHG5 is a novel prognostic biomarker in glioma patients.
    Qian M; Chen Z; Wang S; Guo X; Zhang Z; Qiu W; Gao X; Xu J; Zhao R; Xue H; Li G
    Int J Clin Oncol; 2019 Nov; 24(11):1350-1358. PubMed ID: 31309383
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Ma W; Zhang K; Bao Z; Jiang T; Zhang Y
    Front Immunol; 2021; 12():659659. PubMed ID: 33936093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.